New hope for advanced cancer patients as experimental drug enters human trials
Disease control
Ongoing
This study tests a new drug called vilastobart, alone or with another drug (atezolizumab), in people with advanced solid tumors that have not responded to standard treatments. The goal is to see if the drug is safe and can shrink tumors. About 136 adults with various advanced can…
Phase: PHASE1, PHASE2 • Sponsor: Xilio Development, Inc. • Aim: Disease control
Last updated May 15, 2026 11:55 UTC